VASCULAR ACCESS SOCIETY OF BRITAIN & IRELAND

Registered charity 1135728 · accounts filings on the Charity Commission register · also known as VASBI

This society holds an annual scientific meeting promoting medical care in the field of dialysis and vascular access. Our income is through membership fees, the cost of attendance at our annual conference and through sponsorship by medical device and pharmaceutical industries. Our annual outgoings currently are related to the running of the annual conference

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£91k
Latest spending
£113k
Registered
2010
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that total unrestricted reserves decreased from £90,312 to £68,739 during the year, resulting in a net outgoing of resources. The charity reported no employees and had no share capital, with member liability limited to £1 each. The independent examiner confirmed that no matters came to their attention requiring further understanding of the accounts.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2024£91k£113k
31/12/2023£77k£66k
31/12/2022£26k£25k
31/12/2021£36k£11k
31/12/2020£21k£13k

Common questions

Is VASCULAR ACCESS SOCIETY OF BRITAIN & IRELAND financially healthy?

Per its FY2024 accounts: The accounts state that total unrestricted reserves decreased from £90,312 to £68,739 during the year, resulting in a net outgoing of resources. The charity reported no employees and had no share capital, with member liability limited to £1 each. The independent examiner confirmed that no matters came to their attention requiring further understanding of the accounts. Its FY2024 accounts were independently examined.